167 related articles for article (PubMed ID: 34753870)
1. Brief Report: Rebound HIV Viremia With Meningoencephalitis After Antiretroviral Therapy Interruption After Allogeneic Bone Marrow Transplant.
Capoferri AA; Redd AD; Gocke CD; Clark LR; Quinn TC; Ambinder RF; Durand CM
J Acquir Immune Defic Syndr; 2022 Mar; 89(3):297-302. PubMed ID: 34753870
[TBL] [Abstract][Full Text] [Related]
2. Short Communication: Persistence of HIV After Allogeneic Bone Marrow Transplant in a Dually Infected Individual.
Capoferri AA; Redd AD; Gocke CD; Clark LR; Ambinder RF; Durand CM
AIDS Res Hum Retroviruses; 2022 Jan; 38(1):33-36. PubMed ID: 34107771
[TBL] [Abstract][Full Text] [Related]
3. Discordance between HIV-1 Population in Plasma at Rebound after Structured Treatment Interruption and Archived Provirus Population in Peripheral Blood Mononuclear Cells.
Hendricks CM; Cash MN; Tagliamonte MS; Riva A; Brander C; Llano A; Salemi M; Stevenson M; Mavian C
Microbiol Spectr; 2022 Aug; 10(4):e0135322. PubMed ID: 35699458
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic bone marrow transplantation with post-transplant cyclophosphamide for patients with HIV and haematological malignancies: a feasibility study.
Durand CM; Capoferri AA; Redd AD; Zahurak M; Rosenbloom DIS; Cash A; Avery RK; Bolaños-Meade J; Bollard CM; Bullen CK; Flexner C; Fuchs EJ; Gallant J; Gladstone DE; Gocke CD; Jones RJ; Kasamon YL; Lai J; Levis M; Luznik L; Marr KA; McHugh HL; Mehta Steinke S; Pham P; Pohlmeyer C; Pratz K; Shoham S; Wagner-Johnston N; Xu D; Siliciano JD; Quinn TC; Siliciano RF; Ambinder RF
Lancet HIV; 2020 Sep; 7(9):e602-e610. PubMed ID: 32649866
[TBL] [Abstract][Full Text] [Related]
5. Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment.
Aamer HA; McClure J; Ko D; Maenza J; Collier AC; Coombs RW; Mullins JI; Frenkel LM
PLoS Pathog; 2020 Aug; 16(8):e1008791. PubMed ID: 32841299
[TBL] [Abstract][Full Text] [Related]
6. Increased Proviral DNA in Circulating Cells Correlates with Plasma Viral Rebound in Simian Immunodeficiency Virus-Infected Rhesus Macaques after Antiretroviral Therapy Interruption.
Ziani W; Shao J; Wang X; Russell-Lodrigue K; Liu YZ; Montaner LJ; Veazey RS; Xu H
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408173
[TBL] [Abstract][Full Text] [Related]
7. Brain Macrophages in Simian Immunodeficiency Virus-Infected, Antiretroviral-Suppressed Macaques: a Functional Latent Reservoir.
Avalos CR; Abreu CM; Queen SE; Li M; Price S; Shirk EN; Engle EL; Forsyth E; Bullock BT; Mac Gabhann F; Wietgrefe SW; Haase AT; Zink MC; Mankowski JL; Clements JE; Gama L
mBio; 2017 Aug; 8(4):. PubMed ID: 28811349
[TBL] [Abstract][Full Text] [Related]
8. Establishment of a Novel Humanized Mouse Model To Investigate
Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
[TBL] [Abstract][Full Text] [Related]
9. Myeloid and CD4 T Cells Comprise the Latent Reservoir in Antiretroviral Therapy-Suppressed SIVmac251-Infected Macaques.
Abreu CM; Veenhuis RT; Avalos CR; Graham S; Parrilla DR; Ferreira EA; Queen SE; Shirk EN; Bullock BT; Li M; Metcalf Pate KA; Beck SE; Mangus LM; Mankowski JL; Mac Gabhann F; O'Connor SL; Gama L; Clements JE
mBio; 2019 Aug; 10(4):. PubMed ID: 31431552
[TBL] [Abstract][Full Text] [Related]
10. Early Antiretroviral Therapy Prevents Viral Infection of Monocytes and Inflammation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
Rabezanahary H; Clain J; Racine G; Andreani G; Benmadid-Laktout G; Borde C; Mammano F; Mesplèdes T; Ancuta P; Zghidi-Abouzid O; Estaquier J
J Virol; 2020 Oct; 94(22):. PubMed ID: 32907978
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
Henrich TJ; Hatano H; Bacon O; Hogan LE; Rutishauser R; Hill A; Kearney MF; Anderson EM; Buchbinder SP; Cohen SE; Abdel-Mohsen M; Pohlmeyer CW; Fromentin R; Hoh R; Liu AY; McCune JM; Spindler J; Metcalf-Pate K; Hobbs KS; Thanh C; Gibson EA; Kuritzkes DR; Siliciano RF; Price RW; Richman DD; Chomont N; Siliciano JD; Mellors JW; Yukl SA; Blankson JN; Liegler T; Deeks SG
PLoS Med; 2017 Nov; 14(11):e1002417. PubMed ID: 29112956
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Intact Proviruses in Blood and Lymph Node from HIV-Infected Individuals Undergoing Analytical Treatment Interruption.
Vibholm LK; Lorenzi JCC; Pai JA; Cohen YZ; Oliveira TY; Barton JP; Garcia Noceda M; Lu CL; Ablanedo-Terrazas Y; Del Rio Estrada PM; Reyes-Teran G; Tolstrup M; Denton PW; Damsgaard T; Søgaard OS; Nussenzweig MC
J Virol; 2019 Apr; 93(8):. PubMed ID: 30700598
[TBL] [Abstract][Full Text] [Related]
13. Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
Cummins NW; Rizza S; Litzow MR; Hua S; Lee GQ; Einkauf K; Chun TW; Rhame F; Baker JV; Busch MP; Chomont N; Dean PG; Fromentin R; Haase AT; Hampton D; Keating SM; Lada SM; Lee TH; Natesampillai S; Richman DD; Schacker TW; Wietgrefe S; Yu XG; Yao JD; Zeuli J; Lichterfeld M; Badley AD
PLoS Med; 2017 Nov; 14(11):e1002461. PubMed ID: 29182633
[TBL] [Abstract][Full Text] [Related]
14. Origin of Rebound Plasma HIV Includes Cells with Identical Proviruses That Are Transcriptionally Active before Stopping of Antiretroviral Therapy.
Kearney MF; Wiegand A; Shao W; Coffin JM; Mellors JW; Lederman M; Gandhi RT; Keele BF; Li JZ
J Virol; 2016 Feb; 90(3):1369-76. PubMed ID: 26581989
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid Metabolism Is Associated with Time to HIV Rebound upon Treatment Interruption.
Giron LB; Papasavvas E; Yin X; Goldman AR; Tang HY; Palmer CS; Landay AL; Li JZ; Koethe JR; Mounzer K; Kostman JR; Liu Q; Montaner LJ; Abdel-Mohsen M
mBio; 2021 Feb; 12(1):. PubMed ID: 33622719
[TBL] [Abstract][Full Text] [Related]
16. Bone Marrow-Derived CD4
Hoang TN; Harper JL; Pino M; Wang H; Micci L; King CT; McGary CS; McBrien JB; Cervasi B; Silvestri G; Paiardini M
J Virol; 2019 Jan; 93(1):. PubMed ID: 30305357
[TBL] [Abstract][Full Text] [Related]
17. HIV RNA Rebound in Seminal Plasma after Antiretroviral Treatment Interruption.
Gianella S; Chaillon A; Chun TW; Sneller MC; Ignacio C; Vargas-Meneses MV; Caballero G; Ellis RJ; Kovacs C; Benko E; Huibner S; Kaul R
J Virol; 2020 Jul; 94(15):. PubMed ID: 32434884
[TBL] [Abstract][Full Text] [Related]
18. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy.
Lerner P; Guadalupe M; Donovan R; Hung J; Flamm J; Prindiville T; Sankaran-Walters S; Syvanen M; Wong JK; George MD; Dandekar S
J Virol; 2011 May; 85(10):4772-82. PubMed ID: 21345945
[TBL] [Abstract][Full Text] [Related]
19. Circulating CD30+CD4+ T Cells Increase Before Human Immunodeficiency Virus Rebound After Analytical Antiretroviral Treatment Interruption.
Prator CA; Thanh C; Kumar S; Pan T; Peluso MJ; Bosch R; Jones N; Milush JM; Bakkour S; Stone M; Busch MP; Deeks SG; Hunt PW; Henrich TJ
J Infect Dis; 2020 Mar; 221(7):1146-1155. PubMed ID: 31677350
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and Phenotypic Diversity of the Replication-Competent HIV Reservoir in Treated Patients.
Nicolas A; Migraine J; Dutrieux J; Salmona M; Tauzin A; Hachiya A; Estaquier J; Molina JM; Clavel F; Hance AJ; Mammano F
Microbiol Spectr; 2022 Aug; 10(4):e0078422. PubMed ID: 35770985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
